Mahana is committed to developing safe and effective products. Below are links to peer-reviewed publications for Parallel1, our IBS treatment.

Interested in our clinical trial?

If you're a qualified healthcare professional interested in participating in a Mahana clinical trial, contact our Clinical Team.

Get in Touch

1 Parallel, formerly known as Regul8, originally was developed by Rona Moss-Morris Ph.D, Head of Psychology Department, King’s College London (KCL) in collaboration with Trudie Chalder, Ph.D, Professor of Cognitive Behavioural Psychotherapy and Alice Sibelli, Ph.D. at KCL and Dr. Hazel Everitt, Professor of Primary Care Research, University of Southampton. Initial clinical funding support was provided by the UK National Institute for Health Research (NIHR)